Ocular Therapeutix (OCUL) Debt to Equity: 2013-2025
Historic Debt to Equity for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to $0.27.
- Ocular Therapeutix's Debt to Equity rose 41.95% to $0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.27, marking a year-over-year increase of 41.95%. This contributed to the annual value of $0.22 for FY2024, which is 69.91% down from last year.
- Ocular Therapeutix's Debt to Equity amounted to $0.27 in Q3 2025, which was up 19.67% from $0.23 recorded in Q2 2025.
- Ocular Therapeutix's 5-year Debt to Equity high stood at $8.29 for Q3 2023, and its period low was $0.16 during Q1 2024.
- In the last 3 years, Ocular Therapeutix's Debt to Equity had a median value of $0.26 in 2025 and averaged $1.88.
- In the last 5 years, Ocular Therapeutix's Debt to Equity soared by 1,876.80% in 2023 and then tumbled by 97.68% in 2024.
- Over the past 5 years, Ocular Therapeutix's Debt to Equity (Quarterly) stood at $0.28 in 2021, then surged by 151.29% to $0.71 in 2022, then grew by 1.12% to $0.72 in 2023, then crashed by 69.91% to $0.22 in 2024, then spiked by 41.95% to $0.27 in 2025.
- Its Debt to Equity stands at $0.27 for Q3 2025, versus $0.23 for Q2 2025 and $0.26 for Q1 2025.